bf/NASDAQ:CTSO_icon.jpeg

COM:CYTOSORBENTS

CytoSorbents Corporation

  • Stock

Last Close

0.89

22/11 21:00

Market Cap

50.31M

Beta: -

Volume Today

76.86K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
463.99K
-
391.80K
15.56%
864.34K
120.61%
1.01M
17.12%
814.82K
19.51%
814.39K
0.05%
1.47M
80.94%
2.39M
62.46%
3.72M
55.39%
4.11M
10.58%
3.57M
13.20%
average payables
793.59K
-
742.26K
6.47%
691.32K
6.86%
1.01M
45.72%
1.45M
43.79%
1.77M
21.94%
2.00M
13.37%
1.94M
3.26%
2.32M
19.77%
2.23M
3.88%
2.73M
22.36%
average receivables
252.40K
-
636.01K
151.99%
733.93K
15.40%
1.04M
41.86%
1.82M
74.77%
3.07M
68.96%
4.21M
36.77%
4.81M
14.46%
4.84M
0.58%
5.09M
5.23%
5.86M
15.06%
book value per share
-1.51
-
0.28
118.23%
0.33
19.74%
-0.02
105.65%
0.37
2,093.84%
0.55
48.33%
0.11
80.78%
2.04
1,825.71%
1.44
29.27%
0.81
43.75%
0.52
35.80%
capex per share
-0.02
-
-0.03
11.44%
-0.03
1.24%
-0.02
9.44%
-0.06
159.54%
-0.05
18.56%
-0.05
4.77%
-0.04
8.38%
-0.10
128.67%
-0.15
50.05%
-0.02
85.85%
capex to depreciation
-3.36
-
-5.60
66.68%
-5.70
1.64%
-3.68
35.30%
-7.69
108.64%
-3.89
49.37%
-2.61
32.85%
-2.54
2.96%
-3.79
49.41%
-5.70
50.52%
-0.46
91.90%
capex to operating cash flow
0.06
-
0.06
11.07%
0.07
29.52%
0.09
23.88%
0.26
193.57%
0.14
46.00%
0.09
35.33%
0.30
229.21%
0.31
2.37%
0.23
25.20%
0.04
81.09%
capex to revenue
-0.26
-
-0.12
55.64%
-0.16
35.84%
-0.07
54.26%
-0.13
72.80%
-0.08
40.14%
-0.07
11.05%
-0.04
36.37%
-0.11
151.23%
-0.22
105.99%
-0.03
88.29%
cash per share
0.23
-
0.39
66.88%
0.30
21.81%
0.21
31.65%
0.63
204.17%
0.73
16.08%
0.38
47.92%
1.84
385.13%
1.20
34.64%
0.51
57.73%
0.32
37.74%
days of inventory on hand
46.90
-
92.02
96.22%
196.42
113.46%
76.99
60.80%
52.63
31.65%
40.60
22.85%
104.78
158.06%
88.30
15.73%
157.46
78.32%
90.52
42.51%
96.24
6.32%
days payables outstanding
150.18
-
119.39
20.50%
112.94
5.40%
122.79
8.72%
103.63
15.60%
95.79
7.56%
101.06
5.50%
60.60
40.04%
92.67
52.93%
43.28
53.29%
99.43
129.72%
days sales outstanding
201.21
-
95.05
52.76%
58.40
38.56%
63.76
9.19%
60.17
5.64%
71.07
18.11%
71.62
0.78%
47.73
33.36%
41.16
13.76%
70.43
71.10%
60.82
13.64%
debt to assets
0.41
-
0.10
76.03%
0.06
40.18%
0.51
769.55%
0.41
18.18%
0.30
26.77%
0.59
93.97%
0.01
98.06%
0.15
1,249.71%
0.29
86.94%
0.10
64.77%
debt to equity
-0.12
-
0.21
280.60%
0.08
61.63%
-10.36
13,071.28%
0.97
109.40%
0.59
39.71%
4.72
703.59%
0.01
99.72%
0.22
1,600.36%
0.52
133.58%
0.23
54.89%
dividend yield
0.00
-
earnings yield
-0.16
-
-0.07
58.92%
-0.06
9.93%
-0.09
46.82%
-0.05
45.27%
-0.07
47.10%
-0.16
123.74%
-0.03
83.67%
-0.14
433.66%
-0.49
259.40%
-0.58
18.37%
enterprise value
28.96M
-
139.50M
381.65%
133.30M
4.45%
138.28M
3.74%
172.16M
24.50%
235.78M
36.96%
128.07M
45.68%
238.99M
86.61%
143.36M
40.02%
63.64M
55.60%
53.75M
15.55%
enterprise value over ebitda
-6.23
-
-19.17
207.62%
-13.29
30.65%
-12.81
3.64%
-15.54
21.34%
-15.52
0.14%
-6.75
56.50%
-23.05
241.43%
-7.11
69.16%
-2.19
69.20%
-1.88
13.93%
ev to operating cash flow
-8.30
-
-20.94
152.30%
-14.80
29.35%
-20.54
38.85%
-26.65
29.71%
-21.75
18.37%
-7.64
64.87%
-42.58
457.13%
-10.24
75.96%
-2.25
77.98%
-2.48
10.11%
ev to sales
35.24
-
44.36
25.86%
32.87
25.91%
16.85
48.73%
12.87
23.65%
11.64
9.51%
5.63
51.68%
6.06
7.68%
3.57
41.00%
2.17
39.35%
1.48
31.78%
free cash flow per share
-0.39
-
-0.49
24.50%
-0.39
20.63%
-0.29
25.73%
-0.29
2.32%
-0.40
36.51%
-0.57
40.85%
-0.19
66.86%
-0.42
124.60%
-0.80
88.77%
-0.51
36.46%
free cash flow yield
-0.13
-
-0.05
60.90%
-0.07
41.79%
-0.05
24.10%
-0.05
14.21%
-0.05
9.82%
-0.15
195.59%
-0.02
83.99%
-0.10
327.22%
-0.51
410.28%
-0.46
11.27%
graham net net
-1.66
-
0.13
108.08%
0.22
66.35%
-0.13
160.51%
0.20
248.56%
0.32
61.31%
-0.23
170.25%
1.70
847.49%
0.71
57.92%
0.01
99.14%
-0.21
3,558.08%
graham number
4.10
-
2.00
51.16%
1.56
22.30%
0.44
71.51%
1.60
260.75%
2.64
64.69%
1.19
54.73%
3.04
155.13%
4.29
40.86%
3.71
13.52%
2.74
26.23%
income quality
0.75
-
0.71
4.20%
1.11
55.04%
0.56
49.11%
0.76
35.44%
0.63
17.52%
0.87
38.12%
0.72
17.66%
0.57
20.38%
0.86
50.88%
0.76
11.72%
intangibles to total assets
0.09
-
0.07
26.12%
0.07
4.17%
0.12
79.17%
0.08
37.94%
0.08
5.13%
0.12
53.12%
0.05
61.76%
0.05
11.89%
0.07
32.19%
0
100%
interest coverage
-11.15
-
-23.48
110.64%
-1.00K
4,160.37%
49.58
104.96%
13.14
73.50%
-10.67
181.18%
-18.36
72.08%
-8.63
52.96%
-237.73
-
-193.51
18.60%
interest debt per share
0.22
-
0.08
63.96%
0.03
66.13%
0.18
588.49%
0.33
81.91%
0.37
10.89%
0.53
43.31%
0.06
89.20%
0.32
454.90%
0.42
32.35%
0.12
70.41%
inventory turnover
7.78
-
3.97
49.04%
1.86
53.15%
4.74
155.13%
6.94
46.30%
8.99
29.61%
3.48
61.25%
4.13
18.66%
2.32
43.92%
4.03
73.95%
3.79
5.95%
invested capital
-0.12
-
0.21
280.60%
0.08
61.63%
-10.36
13,071.28%
0.97
109.40%
0.59
39.71%
4.72
703.59%
0.01
99.72%
0.22
1,600.36%
0.52
133.58%
0.23
54.89%
market cap
29.50M
-
143.11M
385.08%
138.61M
3.14%
138.61M
0.00%
179.49M
29.49%
248.21M
38.29%
124.18M
49.97%
309.39M
149.14%
181.67M
41.28%
67.54M
62.82%
49.57M
26.61%
net current asset value
-14.82M
-
3.10M
120.92%
6.82M
119.82%
-2.34M
134.32%
6.90M
394.89%
12.45M
80.48%
-3.06M
124.60%
71.72M
2,441.43%
37.36M
47.91%
5.90M
84.20%
-4.28M
172.55%
net debt to ebitda
0.12
-
0.50
327.42%
0.53
7.05%
0.03
94.17%
0.66
2,041.78%
0.82
23.62%
-0.21
125.07%
6.79
3,410.16%
1.90
72.01%
0.13
92.95%
-0.15
209.45%
net income per share
-0.50
-
-0.65
30.79%
-0.33
49.58%
-0.47
43.66%
-0.31
34.73%
-0.56
82.86%
-0.60
6.61%
-0.20
66.20%
-0.57
180.56%
-0.75
32.95%
-0.64
15.23%
operating cash flow per share
-0.37
-
-0.46
25.31%
-0.36
21.83%
-0.26
26.90%
-0.23
11.59%
-0.35
50.82%
-0.52
47.24%
-0.14
72.17%
-0.32
123.38%
-0.65
100.60%
-0.48
25.16%
payables turnover
2.43
-
3.06
25.79%
3.23
5.70%
2.97
8.02%
3.52
18.48%
3.81
8.18%
3.61
5.21%
6.02
66.78%
3.94
34.61%
8.43
114.10%
3.67
56.47%
receivables turnover
1.81
-
3.84
111.69%
6.25
62.77%
5.72
8.41%
6.07
5.97%
5.14
15.34%
5.10
0.77%
7.65
50.05%
8.87
15.96%
5.18
41.56%
6.00
15.79%
research and ddevelopement to revenue
2.12
-
0.77
63.46%
0.95
23.43%
0.58
38.93%
0.30
48.09%
0.38
26.02%
0.53
39.28%
0.22
57.96%
0.41
82.90%
0.51
26.09%
0.43
15.97%
return on tangible assets
-1.27
-
-1.18
7.18%
-0.78
34.16%
-1.40
81.00%
-0.38
72.94%
-0.57
50.36%
-0.80
40.37%
-0.09
88.60%
-0.29
216.74%
-0.56
92.59%
-0.54
4.02%
revenue per share
0.09
-
0.22
151.20%
0.16
25.47%
0.32
97.97%
0.48
50.20%
0.66
36.04%
0.71
7.06%
1.02
44.00%
0.93
8.98%
0.67
27.16%
0.81
20.80%
roe
0.33
-
-2.35
817.27%
-0.99
57.89%
25.18
2,642.70%
-0.82
103.27%
-1.02
23.28%
-5.64
454.61%
-0.10
98.24%
-0.39
296.69%
-0.93
136.35%
-1.22
32.04%
roic
0.34
-
-1.46
529.21%
-1.01
30.88%
-2.52
149.98%
-0.45
82.16%
-0.56
24.40%
-0.87
55.63%
-0.11
87.19%
-0.24
119.42%
-0.46
86.37%
-0.71
56.58%
sales general and administrative to revenue
4.24
-
2.17
48.75%
1.98
9.12%
1.50
24.23%
1.15
22.99%
1.13
2.01%
1.07
4.85%
0.80
25.68%
0.96
20.12%
1.26
31.83%
shareholders equity per share
-1.51
-
0.28
118.23%
0.33
19.74%
-0.02
105.65%
0.37
2,093.84%
0.55
48.33%
0.11
80.78%
2.04
1,825.71%
1.44
29.27%
0.81
43.75%
0.52
35.80%
stock based compensation to revenue
0.08
-
0.22
177.73%
0.09
57.40%
0.34
256.42%
0.25
26.29%
0.27
7.38%
0.12
53.09%
0.12
4.34%
0.15
29.63%
0.13
16.32%
10.22K
7,894,015.03%
tangible asset value
-14.63M
-
3.41M
123.28%
7.44M
118.44%
-1.67M
122.39%
8.42M
605.94%
14.31M
69.85%
56.59K
99.60%
74.99M
132,423.87%
57.88M
22.82%
30.98M
46.46%
23.28M
24.88%
tangible book value per share
-1.55
-
0.24
115.28%
0.30
26.25%
-0.07
121.90%
0.31
565.99%
0.47
52.68%
0.00
99.62%
1.93
110,015.97%
1.33
30.91%
0.71
46.73%
0.52
26.70%
working capital
422.04K
-
3.10M
634.77%
6.82M
119.82%
1.74M
74.49%
12.89M
641.37%
21.73M
68.54%
10.97M
49.53%
72.30M
559.31%
50.61M
30.00%
24.05M
52.49%
11.16M
53.60%

All numbers in (except ratios and percentages)